• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ImmunoGen Inc

+ Add to Watchlist


13.9900 USD 0.2200 1.55%

As of 20:10:00 ET on 04/17/2014.

Snapshot for ImmunoGen Inc (IMGN)

Open: 14.1900 Day's Range: 13.6950 - 14.3300 Volume: 1,829,858
Previous Close: 14.2100 52wk Range: 11.7775 - 20.2499 1-Yr Rtn: -6.73%

Stock Chart for IMGN

No chart data available.
  • IMGN:US 13.9900
  • 1D
  • 1M
  • 1Y
Interactive IMGN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IMGN

Current P/E Ratio (ttm) -
Estimated P/E(06/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.3703
Est. EPS (USD) (06/2014) -0.6760
Est. PEG Ratio -
Market Cap (M USD) 1,198.56
Shares Outstanding (M) 85.67
30 Day Average Volume 976,123
Price/Book (mrq) 9.2124
Price/Sale (ttm) 15.6076
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/25/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IMGN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for IMGN

ImmunoGen, Inc. develops targeted anticancer therapeutics using its Targeted Antibody Payload (TAP) technology together with its expertise in monoclonal antibodies and tumor biology. A TAP compound uses a tumor-targeting monoclonal antibody to deliver one of ImmunoGen's purpose-developed cancer-killing agents specifically to tumor cells.

Daniel M Junius "Dan"President/CEODavid B Johnston "Dave"Exec VP/CFO
John M LambertExec VP/Chief Scientific OfcrCharles Q Morris "Charlie"Exec VP/Chief Development Ofcr
More Company Profile & Key Executives for IMGN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil